INDIVIDUAL POSTDOCTORAL NRSA FELLOWSHIP IN EPIDEMIOLOGY /CLINICAL TRIALS 
RESEARCH /OUTCOMES RESEARCH IN SKIN DISEASES

Release Date:  March 13, 2000

RFA:  AR-00-003

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Application Receipt Date:  May 11, 2000.

PURPOSE

Progress in the treatment of skin diseases has been hampered by a lack of 
baseline data concerning prevalence and the effectiveness of therapeutic 
interventions in all but the most common skin diseases.  Part of this problem 
is the lack of trained individuals within the skin disease community capable 
of designing and carrying out these studies.  In response, the NIAMS along 
with the Herzog Foundation announces the availability of individual NRSA 
postdoctoral fellowships to support the training of physicians with expertise 
in clinical dermatology to supplement that knowledge with training in 
epidemiology/clinical trials/outcomes research.  These fellowships are 
intended to support up to two years of advanced training in the relevant
methodologies which is to be used to obtain a Masters of Public Health and or 
a Ph.D. in epidemiology to qualify the fellow to pursue a career in these 
areas as they relate to skin diseases.  Therefore, a special feature of this 
award is the inclusion of tuition and fees for the necessary course work which 
is to be taken at a School of Public Health.  An additional unique feature is 
the cooperation of the Herzog Foundation which will directly provide 
supplementation of approximately $ 30,000 per year per fellow to supplement 
the stipend and any other expenses involved in the training.  The intent of 
this announcement is to begin to train a cadre of investigators who will be 
both experienced clinicians in dermatology as well as in the sciences 
underpinning epidemiology/clinical trials/outcomes research so that in the 
future this data will become available to the skin disease community.  

HEALTHY PEOPLE 2010

The Public Health Service (PHS) is committed to achieving the health promotion 
and disease prevention objectives of “Healthy People 2010,” a PHS led national 
activity for setting priority areas.  This Request for Applications (RFA) for 
Individual Postdoctoral NRSA Fellowships in Epidemiology/Clinical 
Trials/Outcomes Research in Skin Diseases is related to one or more of the 
priority areas.  Potential applicants may obtain a copy of “Healthy People 
2010" at http://www.health.gov/healthypeople  


ELIGIBILITY REQUIREMENTS


The candidate must have an M.D. degree and have completed at least two years 
of clinical dermatology training in an accredited program prior to the 
commencement of the fellowship.  Clinical dermatology training may not have 
been completed more than five years prior to submission of the application.  
The individual must also meet the criteria for NIH National Research Service 
Awards for Individual Postdoctoral Fellows (F32) described in Program 
Announcement PA-99-025 available in the NIH Guide for Grants and Contracts 
(Release date December 11, 1998; available at 
http://grants.nih.gov/grants/guide/pa-files/PA-99-025.html).  Racial/ethnic 
minority individuals, women, and persons with disabilities are encouraged to 
apply.  By the time of award, individuals must be citizens or non-citizen 
nationals of the United States, or have been lawfully admitted to the United 
States for permanent residence (i.e., possess a currently valid Alien 
Registration Receipt Card I-551, or other legal verification of such status). 
 Non-citizen nationals are generally persons born in outlying possessions of 
the United States (i.e., American Samoa and Swains Island).  Individuals on 
temporary or student visas are not eligible.

Before submitting a fellowship application, the applicant must identify a 
sponsoring institution and an individual who will serve as a sponsor (also 
called mentor or supervisor) who will supervise the training and research 
experience.  The sponsoring institution may be private (profit or nonprofit) 
or public, including the NIH Intramural Programs and other Federal 
laboratories.  The applicant’s sponsor should be an active investigator in 
either skin disease research or epidemiology/clinical trials/outcomes 
research.  In some instances, it may be advisable for a secondary sponsor to 
complement the primary sponsors’ expertise.  The sponsor must document the 
availability of staff research support, didactic training and facilities for 
high quality research training.

MECHANISM OF SUPPORT

This RFA will use the National Institutes of Health (NIH) Individual 
Postdoctoral NRSA Fellowship Award (F32) mechanism.  The total project period 
for an application submitted in response to this RFA may not exceed a total of 
two years.  The requested project period should be reduced by the amount of 
time a fellow has received support on any prior NRSA post-doctoral fellowship 
including Institutional NRSA training grants (T32s) so that the total NRSA 
postdoctoral support does not exceed 3 years.  For further information refer 
to the NIH Guidelines for the NIH National Research Service Awards for 
Individual Postdoctoral Fellows (F32) published in the NIH Guide for Grants 
and Contracts (PA-99-025) 
http://grants.nih.gov/grants/guide/pa-files/PA-99-025.html.

FUNDS AVAILABLE
 
The NIAMS intends to fund up to 9 new applications responding to this RFA in 
FY 2001 subject to the availability of resources and receipt of sufficiently 
meritorious applications.  The estimated funds (total costs) available for the 
first year of support of this program is $300,000.					
					

RESEARCH OBJECTIVES


The overall goal of this research training initiative is to increase the 
number of clinically trained dermatologists who have the appropriate training 
and advanced degrees in epidemiology/clinical trials/outcome research to 
pursue a career focused on this combined area of investigation.  The secondary 
goal is to enhance the visibility of this discipline at U.S. academic health 
centers.

INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS

It is the policy of the NIH that women and members of minority groups and 
their subpopulations must be included in all NIH supported biomedical and 
behavioral research projects involving human subjects, unless a clear and 
compelling rationale and justification is provided that inclusion is 
inappropriate with respect to the health of the subjects or the purpose of the 
research.  This policy results from the NIH Revitalization Act of 1993 
(Section 492B of Public Law 103-43).  All investigators proposing research 
involving human subjects should read the ANIH Guidelines for Inclusion of 
Women and Minorities as Subjects in Clinical Research, which have been 
published in the Federal Register of March 28, 1994 (FR 59 14508-14513) and in 
the NIH Guide for Grants and Contracts, Vol. 23, No. 11, March 18, 1994 
available on the web at the following URL address: 
http://grants.nih.gov/grants/guide/notice-files/not94-100.html.

INCLUSION OF CHILDREN AS PARTICIPANTS IN RESEARCH INVOLVING HUMAN SUBJECTS

It is the policy of NIH that children (i.e., individuals under the age of 21) 
must be included in all human subjects research, conducted or supported by the 
NIH, unless there are scientific and ethical reasons not to include them.  
This policy applies to all initial (Type 1) applications submitted for receipt 
dates after October 1, 1998.  All investigators proposing research involving 
human subjects should read the “NIH Policy and Guidelines on the Inclusion of 
Children as Participants in Research Involving Human Subjects” that was 
published in the NIH Guide for Grants and Contracts, March 6, 1998, and is 
available at the following URL address: 
http://grants.nih.gov/grants/guide/notice-files/not98-024.html.

Investigators also may obtain copies of these policies from the program staff 
listed under INQUIRIES.  Program staff may also provide additional relevant 
information concerning the policy.

APPLICATION PROCEDURES


Applications are to be submitted on the form PHS 416-1 (rev. 12/98) available 
at: http://grants.nih.gov/grants/forms.htm.  Application kits are available 
from most institutional offices of sponsored research and from the Division of 
Extramural Outreach and Information Resources, National Institutes of Health, 
6701 Rockledge Drive, MSC 7910; Bethesda, MD 20892-7710, telephone (301) 435-
0714, email: grantsinfo@nih.gov.  Information on the current stipend levels 
may be found at: 
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-008.html. Applications 
for fellowship awards must include at least three sealed letters of reference.  
Fellowship application submitted without the required number of reference 
letters will be considered incomplete and will be returned without review.

The title and number of this RFA must be typed on line 2 (item number 3) of 
the face page of the application form.

The sample RFA label available at: 
http://grants.nih.gov/grants/funding/phs398/label-bk.pdf has been modified to 
allow for this change.  Please note this is in pdf format.

The original and two copies of the application must be submitted to:

CENTER FOR SCIENTIFIC REVIEW
NATIONAL INSTITUTES OF HEALTH
6701 ROCKLEDGE DRIVE, ROOM 1040, MSC-7710
BETHESDA, MD 20892-7710
BETHESDA, MD 20817 (for express/courier service)

REVIEW CONSIDERATIONS

Applications to this RFA will be assigned to NIAMS.  Applications submitted in 
response to this RFA will be reviewed in accordance with the standard NIH peer 
review procedures.  The following factors are considered in the review of 
fellowship applications: (1) the candidate’s potential for a research career; 
(2) the scientific or scholarly merit and training potential of the research 
proposal; (3) the training environment and resources; and (4) assessment of 
the value of the proposed fellowship experience.  The second level of review 
is performed by the appropriate oversight group of the NIH awarding component.

AWARD CRITERIA

Applications will compete for available training funds set aside for this RFA. 
 Up to ten awards will be made dependent upon the quality of the applications 
received.  The following will be considered in funding decisions: Quality of 
the fellowship applications determined by peer review and availability of 
funds.

ADDITIONAL CONSIDERATIONS

The Herzog Foundation has agreed to provide approximately $ 30,000 per year 
(direct costs) to each successful applicant to supplement the available 
stipend and/or any other costs associated with this mechanism that might not 
otherwise be covered in the NRSA award.  These monies will be made available 
to the sponsoring institution by the Herzog Foundation specifically earmarked 
for the support of the individual receiving this award. These funds will be 
provided according to the sponsoring institution’s own formally established 
policies and must be consistently applied regardless of the source of funds.

Reimbursement for tuition and fees for the didactic components of the training 
plan may also be budgeted pursuant to NRSA guidelines.  

INQUIRIES

Inquiries are strongly encouraged.  The opportunity to clarify any issues or 
questions from potential applicants is welcome.

Direct inquiries regarding programmatic issues to:

Alan N. Moshell, M.D.
Skin Diseases Program Director							
National Institute of Health
National Institute of Arthritis and Musculoskeletal and Skin Disease
45 Center Drive, Room 5AS-25L, MSC-6500
Bethesda, MD 20892-6500
Telephone: 301-594-5017
FAX:          301-480-4543
Email:         alan_n_moshell@nih.gov

Direct inquires regarding fiscal matters to:

Leslie D. Boggs
Grants Management Specialist
GMB, NIAMS, NIH
45 Center Drive, Room 5AS-43H, MSC-6500
Bethesda, MD 20892-6500
Telephone: 301-594-3968
FAX:          301-480-5450
Email:         boggsl@mail.nih.gov

AUTHORITY AND REGULATIONS

NRSA awards are made under the authority of Section 487 of the Public Health 
Service Act as amended (42 USC 288) and Title 42 of the Code of Federal 
Regulations, Part 66.  The Catalog of Federal Domestic Assistance Number is 
93.846 .  This program is not subject to the intergovernmental review 
requirements of Executive Order 12372 or Health Systems Agency review.

The PHS strongly encourages all grant and contract recipients to provide a 
smoke-free workplace and promote the non-use of all tobacco products.  In 
addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking 
in certain facilities (or in some cases, any portion of a facility) in which 
regular or routine education, library, day care, health care or early 
childhood development services are provided to children.  This is consistent 
with the PHS mission to protect and advance the physical and mental health of 
the American people.


Return to Volume Index

Return to NIH Guide Main Index


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.